|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institut de Biologia Molecular de Barcelona-CSIC and Institut de Recerca Biomedica, Parc Cientific de Barcelona, 08028 Barcelona, Spain
2 Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain
(RECEIVED May 2, 2007; FINAL REVISION June 6, 2007; ACCEPTED June 6, 2007)
| Abstract |
|---|
|
|
|---|
Keywords: plant enzymes; MEP pathway; isoprenoid-binding proteins; cytidine-5-monophosphate; zinc ions
| Introduction |
|---|
|
|
|---|
In the synthesis of isoprenoids, the MEP pathway is the only one present in most eubacteria, including the causal agents for diverse and serious human diseases like leprosy, bacterial meningitis, various gastrointestinal and sexually transmitted infections, tuberculosis, and certain types of pneumonia. The MEP pathway is the only one present in some protozoans, such as in the malaria parasite Plasmodium falciparum. In turn, the MEP pathway is absent from Archaea, fungi, and animals that synthesize their isoprenoids exclusively through the MVA pathway (Eisenreich et al. 1998; Rohmer 1999; Boucher and Doolittle 2000; Rodriguez-Concepcion and Boronat 2002; Testa and Brown 2003; Rohmer et al. 2004). Plants use both pathways, although they localize in different cellular compartments: the chloroplasts and the cytoplasm for the MEP and the MVA pathways, respectively (Rodriguez-Concepcion and Boronat 2002). Given the essential nature of the MEP pathway and its absence in mammals, the enzymes comprising the MEP pathway represent potential targets for the generation of selective antibacterial, antimalarial, and herbicidal compounds (Jomaa et al. 1999; Lichtenthaler et al. 2000; Rodriguez-Concepcion and Boronat 2002; Testa and Brown 2003; Rohmer et al. 2004).
As part of a general study about isoprenoid synthesis in plants, we have investigated the enzyme 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS, E.C. 4.6.1.12 [EC] ) from the fifth stage of the MEP pathway in Arabidopsis thaliana. MCS converts 4-diphosphocytidyl 2C-methyl-D-erythritol 2-phosphate (CDP-MEP) to 2C-methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) and cytidine-5-monophosphate (CMP). The MCS enzyme from Escherichia coli, encoded by the ispF gene, was the first to be identified (Herz et al. 2000), and since then homologs from a number of microorganisms and plants have been characterized (Rodriguez-Concepcion and Boronat 2002; Testa and Brown 2003; Gao et al. 2006; Hsieh and Goodman 2006).
The three-dimensional structures of five bacterial MCS enzymes have been reported: from E. coli (Kemp et al. 2002; Richard et al. 2002; Steinbacher et al. 2002), Haemophilus influenzae (Lehmann et al. 2002), the thermophile Thermus thermophilus (Kishida et al. 2003), Shewanella oneidensis (Ni et al. 2004), and the MCS domain of a bifunctional IspDF enzyme from Campylobacter jejuni (Gabrielsen et al. 2004). In this work, we present the X-ray crystal structure of the MCS enzyme from A. thaliana, the first determined from a plant. The main structural differences with respect to the bacterial enzymes reside in the organization of the large molecular cavity that forms between the three subunits of the MCS molecule. For bacteria, this cavity is proposed to be an isoprenoid diphosphate-like binding pocket (IPPbp) having a feedback-regulatory function (Richard et al. 2002; Ni et al. 2004; Kemp et al. 2005). In the MCS from A. thaliana, the cavity architecture impedes the binding of diphosphate-containing molecules due to the presence of several residues that are highly conserved in plants. Changes of the effectors that could bind to this cavity appear to imply a different regulatory mechanism of the MEP pathway between bacteria and plants.
| Results and Discussion |
|---|
|
|
|---|
|
atoms. The subunit is organized as a single structural domain, including a long four-stranded mixed
-sheet and three
-helices located on one side of the sheet (a cartoon representation of the monomer is shown in Fig. 2A). In the crystal of MCS from A. thaliana, six neighbor monomers with large contact surfaces are related by ternary and binary crystallographic symmetries with a D3 point group symmetry (Fig. 2A,B). However, gel-filtration studies indicate that, in solution, the MCS molecule from A. thaliana is a trimer, similarly to what had been observed in the bacterial enzymes (data not shown). In fact, the three subunits that relate by the crystal threefold axis in the A. thaliana structure give a RMSD of only 1.07 Å when superimposed to the equivalent C
atoms of the MCS molecular trimers from E. coli. These MCS trimers have a length of
48 Å along the threefold symmetry axis and are shaped like extended trigonal prisms with a flat-bottom side, of
34 Å in diameter, and a narrower top side (Fig. 2A). The
-sheets of the three subunits face one another, defining an internal
-barrel like structure that is surrounded by the
-helices on the external surface of the trimer. In the trimer, extensive inter-subunit interactions define a network of complementary hydrophobic contacts, electrostatic interactions, and specific hydrogen bonds, similarly to what was described for the bacterial MCS enzymes (Kemp et al. 2002; Lehmann et al. 2002; Richard et al. 2002; Steinbacher et al. 2002; Ni et al. 2004).
|
|
and
phosphate groups of the CDP moiety (Kemp et al. 2002; Steinbacher et al. 2002; Kishida et al. 2003; Sgraja et al. 2005). No hints of a second bound metal were found in the A. thaliana structure complexed with CMP.
Inter-subunits' binding cavity
In the MCS homotrimer from A. thaliana, the
-sheets of the three subunits define an internal cavity
15 Å in length along the ternary symmetry axis (Fig. 3). An equivalent, somewhat larger, cavity was found in the bacterial enzymes and shown to be an isoprenoid diphosphate-like binding pocket (IPPbp) with a proposed product feedback regulatory function through a yet undetermined mechanism (Richard et al. 2002; Ni et al. 2004; Kemp et al. 2005), which might be related with the trimer stability. However, such a cavity is absent in the thermophilic MCS enzyme from Thermus thermophilus, where packing of subunits is tighter and likely more stable according to ultracentrifugation data (Kishida et al. 2003).
|
In A. thaliana the walls of the cavity are lined with hydrophobic (Phe81, Leu83, Ile173, Leu214) and polar (His208, Asp212, Ser213) residues, not well preserved between plants and bacteria (Fig. 3). In the lower part of the cavity, Asp212 forms a narrow negatively charged ring with the corresponding carboxylate groups at only 2.54 Å from the threefold axis (Fig. 3A). An aspartate in this position appears to be a highly conserved feature among the plant MCS enzymes, while in bacteria the position corresponds to residues with small side chains, such as Gly138 in E. coli (Figs. 1, 3B). The bottom of the cavity presents an aperture that is defined by a ring of salt bridges, involving residues Glu216 and Arg218 from the three subunits (Fig. 3A). These charged residues are highly conserved in MCS sequences, although in bacteria their positions are interchanged (Figs. 1, 3).
The A. thaliana cavity is occupied by bulky fragments of electron density whose interpretation appears to be complicated by the averaging effect of the threefold crystal symmetry. Electron density had also been found inside the cavities of other reported MCS structures (Kemp et al. 2002; Lehmann et al. 2002; Richard et al. 2002; Ni et al. 2004). For the bacterial structures from E. coli (Richard et al. 2002; Kemp et al. 2005), S. oneidensis (Ni et al. 2004), and C. jejuni (IspDF, a bifunctional enzyme); (Gabrielsen et al. 2004), the electron density inside the cavity was interpreted as GPP or as farnesyl diphosphate (FPP) with the diphosphate moieties positioned along the molecular threefold axis and the
-phosphate group interacting with the arginines at the cavity entrance (Fig. 3B,C). For the H. influenzae structure (Ni et al. 2004), the density inside the cavity was interpreted as a sulfate ion interacting with the arginines at the cavity entrance (Fig. 3D). In the A. thaliana structure, the first fragment of density inside the cavity is located above Asp212, far from the corresponding arginine (Arg218) at the cavity entrance. For this density a phosphate ion was modeled interacting, throughout water molecules, with the side chains of His208 and of its symmetry mates (Fig. 3A). Therefore, the peculiarities of the cavity in the plant enzymes are suited for the binding of molecules with a monophosphate moiety, although they discard, in particular due to the presence of Asp212, the binding of diphosphate-containing molecules, such as isoprenoids GPP or FPP.
Conclusions
The first crystal structure from a plant MCS enzyme has been determined, in complex with a CMP molecule. The molecular trimeric organization and the overall structure of subunits, in particular the arrangement of the catalytically essential residues and of the Zn2+ ion in the active site, are closely related to the ones from the known structures of the bacterial enzymes. Main differences between the plant and the bacterial MCS structures concentrate in the cavity that exists between subunits along the molecular threefold axis and involve residues that are highly conserved among plants. These differences suggest that the binding of isoprenoid diphosphate-like molecules in the cavity of the plant MCS enzymes would not occur, contrary to what had been demonstrated for some bacterial enzymes.
| Materials and Methods |
|---|
|
|
|---|
Expression and purification of MCS
The pET23b-MCS clone was heterologously expressed in E. coli BL21 (pLysS). One liter of bacterial cells was grown up to an OD600 of 0.5 at 37°C in LB broth. For optimal protein expression, the bacterial culture was induced with 0.5 mM IPTG and incubated overnight at 22°C. Cells were harvested by centrifugation at 5000g (4°C), resuspended in 20 mL lysis buffer (20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 1 mg/mL lysozyme, 0.5 mM EDTA supplemented with a cocktail of protease inhibitors [Roche]), and lysed by sonication (5 x 30 sec, 30 W). The lysate was then incubated with 1% (w/v) protamine sulfate, and the soluble fraction was obtained by centrifugation at 20,000g for 45 min at 4°C. The recombinant protein present in the cleared lysate was purified through a Ni2+ affinity chromatography column (GE Healthcare), and the total protein yield was
60 mg of recombinant protein per liter of culture. This protein sample was loaded into a Superdex 200 gel-filtration column (GE Healthcare) for further purification, and the protein was then concentrated to 6 mg/mL.
Crystal preparation and structure determination
Crystals of the MCS protein were obtained by the hanging-drop vapor-diffusion method at 20°C. Drops were assembled from 1 µL of protein solution (at a concentration of 6 mg/mL) containing 2 mM CMP and 2 mM MgCl2 in 40 mM Tris (pH 8.0) and 1 µL of reservoir solution composed of 100 mM MES (pH 6.0), 200 mM NH4H2PO4, and 18% (w/v) PEG 3350. The crystals, belonging to the cubic space group I4132, contained one protein subunit per asymmetric unit and grew within 5 d to a maximum final size of 0.2 mm. Macroseeding was necessary for reproducible crystallization.
Crystals were flash-cooled in liquid nitrogen in the presence of 20% (v/v) glycerol. Diffraction data, collected to 2.3 Å resolution in the ESRF beamline ID29, were indexed, integrated, and scaled using DENZO/SCALEPACK (Table 1 [Otwinowski and Minor 1997]). General data handling was carried out with programs from the CCP4 suite (Collaborative Computational Project No. 4 1994). The structure was determined by molecular replacement with the program MOLREP (Vagin and Teplyakov 1997) using the E. coli MCS structure (PDB accession code 1GX1 [PDB] ) as the search model. Model completion and rebuilding were performed interactively with the graphics program COOT (Emsley and Cowtan 2004). Solvent molecules, CMP, Zn2+, and Cl– were identified by inspection of electron density and difference density maps. Coordinates and temperature B factors were refined using REFMAC (Table 1; Murshudov et al. 1997).
Figures were prepared with PyMOL (DeLano 2002). Coordinates and structure factors have been deposited at the PDB under accession code 2PMP.
| Footnotes |
|---|
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.072972807.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Chappell, J. 2002. The genetics and molecular genetics of terpene and sterol origami. Curr. Opin. Plant Biol. 5: 151–157.[CrossRef][Medline]
Collaborative Computational Project, Number 4 (CCP4) 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760–763.[CrossRef][Medline]
DeLano, W. 2002. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA, http://www.pymol.org.
Eisenreich, W., Schwarz, M., Cartayrade, A., Arigoni, D., Zenk, M.H., and Bacher, A. 1998. The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms. Chem. Biol. 5: R221–R233.[CrossRef][Medline]
Emsley, P. and Cowtan, K. 2004. COOT: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126–2132.[CrossRef][Medline]
Flesch, G. and Rohmer, M. 1988. Prokaryotic hopanoids: The biosynthesis of the bacteriohopane skeleton. Formation of isoprenic units from two distinct acetate pools and a novel type of carbon/carbon linkage between a triterpene and D-ribose. Eur. J. Biochem. 175: 405–411.[Medline]
Gabrielsen, M., Bond, C.S., Hallyburton, I., Hecht, S., Bacher, A., Eisenreich, W., Rohdich, F., and Hunter, W.N. 2004. Hexameric assembly of the bifunctional methylerythritol 2,4-cyclodiphosphate synthase and protein—protein associations in the deoxy-xylulose–dependent pathway of isoprenoid precursor biosynthesis. J. Biol. Chem. 279: 52753–52761.
Gao, S., Lin, J., Liu, X., Deng, Z., Li, Y., Sun, X., and Tang, K. 2006. Molecular cloning, characterization and functional analysis of a 2C-methyl-d-erythritol 2,4-cyclodiphosphate synthase gene from ginkgo biloba. J. Biochem. Mol. Biol. 39: 502–510.[Medline]
Herz, S., Wungsintaweekul, J., Schuhr, C.A., Hecht, S., Luttgen, H., Sagner, S., Fellermeier, M., Eisenreich, W., Zenk, M.H., Bacher, A., et al. 2000. Biosynthesis of terpenoids: YgbB protein converts 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate to 2C-methyl-D-erythritol 2,4-cyclodiphosphate. Proc. Natl. Acad. Sci. 97: 2486–2490.
Hsieh, M.H. and Goodman, H.M. 2006. Functional evidence for the involvement of Arabidopsis IspF homolog in the non-mevalonate pathway of plastid isoprenoid biosynthesis. Planta 223: 779–784.[CrossRef][Medline]
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Turbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H.K., et al. 1999. Inhibitors of the non-mevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285: 1573–1576.
Kemp, L.E., Bond, C.S., and Hunter, W.N. 2002. Structure of 2C-methyl-d-erythritol 2,4-cyclodiphosphate synthase: An essential enzyme for isoprenoid biosynthesis and target for antimicrobial drug development. Proc. Natl. Acad. Sci. 99: 6591–6596.
Kemp, L.E., Alphey, M.S., Bond, C.S., Ferguson, M.A., Hecht, S., Bacher, A., Eisenreich, W., Rohdich, F., and Hunter, W.N. 2005. The identification of isoprenoids that bind in the intersubunit cavity of Escherichia coli 2C-methyl-d-erythritol-2,4-cyclodiphosphate synthase by complementary biophysical methods. Acta Crystallogr. D Biol. Crystallogr. 61: 45–52.[CrossRef][Medline]
Kishida, H., Wada, T., Unzai, S., Kuzuyama, T., Takagi, M., Terada, T., Shirouzu, M., Yokoyama, S., Tame, J.R., and Park, S.Y. 2003. Structure and catalytic mechanism of 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) synthase, an enzyme in the non-mevalonate pathway of isoprenoid synthesis. Acta Crystallogr. D Biol. Crystallogr. 59: 23–31.[CrossRef][Medline]
Lehmann, C., Lim, K., Toedt, J., Krajewski, W., Howard, A., Eisenstein, E., and Herzberg, O. 2002. Structure of 2C-methyl-D-erythrol-2,4-cyclodiphosphate synthase from Haemophilus influenzae: Activation by conformational transition. Proteins 49: 135–138.[CrossRef][Medline]
Lichtenthaler, H.K. 1999. The 1-deoxy-d-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 50: 47–65.[CrossRef][Medline]
Lichtenthaler, H.K., Schwender, J., Disch, A., and Rohmer, M. 1997. Biosynthesis of isoprenoids in higher plant chloroplasts proceeds via a mevalonate-independent pathway. FEBS Lett. 400: 271–274.[CrossRef][Medline]
Lichtenthaler, H.K., Zeidler, J., Schwender, J., and Muller, C. 2000. The non-mevalonate isoprenoid biosynthesis of plants as a test system for new herbicides and drugs against pathogenic bacteria and the malaria parasite. Z. Naturforsch. C 55: 305–313.[Medline]
McGarvey, D.J. and Croteau, R. 1995. Terpenoid metabolism. Plant Cell 7: 1015–1026.[CrossRef][Medline]
Murshudov, G.N., Vagin, A.A., and Dodson, E.J. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53: 240–255.[CrossRef][Medline]
Ni, S., Robinson, H., Marsing, G.C., Bussiere, D.E., and Kennedy, M.A. 2004. Structure of 2C-methyl-d-erythritol-2,4-cyclodiphosphate synthase from Shewanella oneidensis at 1.6 Å: Identification of farnesyl pyrophosphate trapped in a hydrophobic cavity. Acta Crystallogr. D Biol. Crystallogr. 60: 1949–1957.[CrossRef][Medline]
Otwinowski, Z. and Minor, W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307–326.
Richard, S.B., Ferrer, J.L., Bowman, M.E., Lillo, A.M., Tetzlaff, C.N., Cane, D.E., and Noel, J.P. 2002. Structure and mechanism of 2-C-methyl-d-erythritol 2,4-cyclodiphosphate synthase. An enzyme in the mevalonate-independent isoprenoid biosynthetic pathway. J. Biol. Chem. 277: 8667–8672.
Rodriguez-Concepcion, M. and Boronat, A. 2002. Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics. Plant Physiol. 130: 1079–1089.
Rohmer, M. 1999. The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat. Prod. Rep. 16: 565–574.[CrossRef][Medline]
Rohmer, M., Knani, M., Simonin, P., Sutter, B., and Sahm, H. 1993. Isoprenoid biosynthesis in bacteria: A novel pathway for the early steps leading to isopentenyl diphosphate. Biochem. J. 295: 517–524.[Medline]
Rohmer, M., Grosdemange-Billiard, C., Seemann, M., and Tritsch, D. 2004. Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs. Curr. Opin. Investig. Drugs 5: 154–162.[Medline]
Sacchettini, J.C. and Poulter, C.D. 1997. Creating isoprenoid diversity. Science 277: 1788–1789.
Sgraja, T., Kemp, L.E., Ramsden, N., and Hunter, W.N. 2005. A double-mutation of Escherichia coli 2C-methyl-d-erythritol-2,4-cyclodiphosphate synthase disrupts six hydrogen bonds with, yet fails to prevent binding of, an isoprenoid diphosphate. Acta Crystallogr. F Struct. Biol. Cryst. Commun. 61: 625–629.[CrossRef]
Steinbacher, S., Kaiser, J., Wungsintaweekul, J., Hecht, S., Eisenreich, W., Gerhardt, S., Bacher, A., and Rohdich, F. 2002. Structure of 2C-methyl-d-erythritol-2,4-cyclodiphosphate synthase involved in mevalonate-independent biosynthesis of isoprenoids. J. Mol. Biol. 316: 79–88.[CrossRef][Medline]
Testa, C.A. and Brown, M.J. 2003. The methylerythritol phosphate pathway and its significance as a novel drug target. Curr. Pharm. Biotechnol. 4: 248–259.[CrossRef][Medline]
Vagin, A. and Teplyakov, A. 1997. MOLREP: An automated program for molecular replacement. J. Appl. Crystallogr. 30: 1022–1025.[CrossRef]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |